# Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis

> **NCT02185911** · — · COMPLETED · sponsor: **Amgen** · enrollment: 308 (actual)

## Conditions studied

- Anaemia
- Chronic Kidney Disease (CKD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02185911
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 308 (ACTUAL)
- **Last updated:** 2016-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02185911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02185911, "Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02185911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*